BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//IBCG | International Bladder Cancer group - ECPv6.16.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:IBCG | International Bladder Cancer group
X-ORIGINAL-URL:https://ibcg.info
X-WR-CALDESC:Events for IBCG | International Bladder Cancer group
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260827
DTEND;VALUE=DATE:20260830
DTSTAMP:20260707T164322Z
CREATED:20260703T061626Z
LAST-MODIFIED:20260707T164322Z
UID:2115-1787788800-1788047999@ibcg.info
SUMMARY:IBCG26 Annual Retreat
DESCRIPTION:Event Agenda \nFriday\, August 28 – Day 1 \n7:00 – 7:45 am – Breakfast\n7:45 – 8:00 am – Opening Remarks\n8:00 – 8:30 am – Overview of Delphi Methodology and Voting Process \nLocalized Disease (MIBC) Setting \n8:30 – 8:55 am – Defining Clinical Response to Systemic Therapy\n8:55 – 9:20 am – Systemic Therapy After Response\n9:20 – 9:45 am – Local Therapy After Systemic Response\n9:45 – 10:10 am – Patient Perspective on Therapy Selection After Systemic Response \nRegionally Advanced Node-Positive Disease (N1–N3\, M0) \n10:10 – 10:35 am – Response Assessment and Systemic Therapy Modulation\n10:35 – 11:00 am – Definitive Local Therapy in Node-Positive Disease\n11:00 – 11:15 am – Break \nMetastatic Urothelial Cancer (M1+) Setting \n11:15 – 11:40 am – Defining Systemic Therapy Decisions\n11:40 am – 12:05 pm – Role of Local Therapy to Metastatic Sites\n12:05 – 12:30 pm – Role of Local Therapy to Primary Tumor Site\n12:30 – 1:30 pm – Lunch\n1:30 – 4:30 pm – Industry Innovation Forum\n6:30 pm – Depart for Dinner \n  \nSaturday\, August 29 – Day 2 \n7:00 – 7:45 am – Breakfast\n7:45 – 8:30 am – Patient Perspectives Panel & Discussion \nClinical Trial and Translational Science Considerations \n8:30 – 8:55 am – Clinical Trial Design and Implementation in the Current Era\n8:55 – 9:20 am – Incorporating Translational Approaches\n9:20 – 9:45 am – Cost Considerations\n9:45 – 10:10 am – PRO Endpoints for Incorporation in Clinical Trials\n10:10 – 10:20 am – Break \nTURBT Best Practices for Multidisciplinary Bladder Cancer Management \n10:20 – 10:45 am – TURBT in the Context of Radiation Therapy\n10:45 – 11:10 am – TURBT in the Context of Systemic Therapy\n11:10 – 11:35 am – Surgical Technical Considerations\n11:35 am – 12:00 pm – Limiting Procedural Toxicity and Optimizing Peri-Operative Care\n12:00 – 12:25 pm – Pathology and Translational Priorities in TURBT\n12:25 – 1:15 pm – Regulatory Perspectives\n1:15 – 2:00 pm – Next Steps\, Future Projects\, Manuscript Timelines\, Boxed Lunch & Departures
URL:https://ibcg.info/event/ibcg26-annual-retreat/
LOCATION:Houston\, Houston\, TX\, United States
ATTACH;FMTTYPE=image/png:https://ibcg.info/wp-content/uploads/2026/07/IBCG_Logo-scaled.png
END:VEVENT
END:VCALENDAR